September 13, 2020
1 min read

AstraZeneca Trial Resumes In UK

Damascus, Sept. 12, 2020 (Xinhua) -- Rania al-Halabi (L) teaches her son Laith how to use hand cleansing gel at home in Damascus, capital of Syria, Sept. 10, 2020. Instead of helping her son review the lessons, Rania al-Halabi now spends time teaching her fifth-grade boy how to wear a mask and keep a distance at school to protect him from the coronavirus. For al-Halabi and her husband, the school year, which begins on Sept. 13 in Syria, poses a challenge to them amid fears of the COVID-19. They could not even hide their worries about sending their child to school. COVID-19 adds emotional, financial burden to Syrian families with start of school" (Photo by Ammar Safarjalani/Xinhua/IANS)

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.

On September 6, the standard review process had triggered a voluntary pause to vaccination across all global trials to allow a review of safety data by independent committees and international regulators.

COVID-19 vaccine in 1 month? CSIR pins hope on Sepsivac by . The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume, AstraZeneca said on Saturday.

“AstraZeneca and the University of Oxford as the trial sponsor cannot disclose further medical information. All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards,” it added.

AstraZeneca is committed to the safety of the trial participants and the highest standards of conduct in clinical trials.

Prime Minister Boris Johnson holds his first face-to-face cabinet meeting at the Foreign Office since the Covid-19 Lockdown took place in March. Picture by Andrew Parsons / No 10 Downing Street

“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” the company said.

Matt Hancock Digital Covid-19 Press Conference 21/04 by .
Matt Hancock during a Digital Covid-19 Press Conference. (Picture by Andrew Parsons / No 10 Downing Street)

AZD1222 was co-invented by the University of Oxford and its spin-out company, Vaccitech. It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein.

After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.

Also Read-UK goes ahead with controversial market bill

Previous Story

US Remembers 9/11 As Covid Alters Tribute Events

Next Story

Criticism repeats as Bahrain join hands with Israel

Latest from -Top News

India, UK boost ties for clean energy future

Discussions also explored new opportunities in energy storage, green data centres, and offshore wind, particularly benefiting small and medium enterprises (SMEs). India and the UK on Monday reaffirmed their commitment to a

PM Modi’s ‘Pariksha Pe Charcha’ Goes Global

The interactive session for students from classes 6 to 12 dealt with exam-related issues, tips, and stress and guided parents and teachers….reports Asian Lite News Thousands of students from Indian schools across

Modi Departs for Paris to Co-Chair AI Action Summit

During his visit, Modi will also engage in high-level talks with Macron, aiming to further strengthen the India-France strategic partnership. Prime Minister Narendra Modi has departed for Paris, where he will co-chair

Greenwich eyes riverside revival 

Greenwich backs calls for investment to unlock its riverfront’s potential as Deputy Mayor Howard Dawber joins local leaders on a tour of the borough’s scenic Thames-side.  Greenwich has welcomed calls for greater
Go toTop